Ambulatory Cardiac Monitoring Devices Market Size, Growth, Trends, Forecast 2021 to 2030
The global ambulatory cardiac monitoring devices market value reached at US$ 13.4 billion in 2020 and projected to surpass around US$ 28.7 billion by 2030.
Ambulatory cardiac monitor tracks and records heart activity during the day. Most devices are about the size of a mobile phone. Rise in prevalence of cardiac disorders, aging population, and increase in access to healthcare are key factors propelling the global ambulatory cardiac monitoring devices market. Obesity, diabetes mellitus, smoking, high cholesterol, high blood pressure, and sedentary lifestyles are the leading causes of heart failure. The rise in the number of people affected by these diseases fuels the demand for ambulatory cardiac monitoring devices.
The utilization of implantable cardiac monitors has increased to keep track of the irregularity of heart rhythm compared to Holter and other external patch. Insertable cardiac monitors (ICMs, or implantable loop recorders, ILRs) are small subcutaneous devices that continuously monitor the heart rhythm and record events for several years. Insertable cardiac monitors are commonly used to monitor patients with syncope or stroke of unknown origin for infrequent rhythm abnormalities, as well as for long-term monitoring of atrial fibrillation post ablation. ICMs i.e., insertable cardiac monitors, are small, subcutaneously implanted devices offering continuous ambulatory electrocardiogram (ECG) monitoring with a lifespan of up to three years.
Rise in Demand for Prolonged ECG Monitoring, Self-Care Management to Drive Global Market
The steady increase in the usage of ambulatory cardiac monitors for the treatment of cardiac arrhythmia and other cardiac diseases is expected to drive the global market during the forecast period. Ambulatory cardiac monitors are for external as well as internal use. For instance, implantable loop recorders can be implanted subcutaneously with a battery life of three years. This results in prolonged monitoring of electrical activity in the heart. This, in turn, boosts the demand for implantable cardiac monitors. Ambulatory cardiac monitors also promote self-care management, owing to continuous monitoring and reporting of irregular heartbeats to the physician. These monitors have made data transmission easier.
Most people have cellphones with them all the times and hence, it is feasible to consider mHealth as an effective mechanism not only to transmit real-time ECG data to a healthcare provider and receive immediate feedback, but also to improve patient engagement and self-management.
Increase in Burden of Cardiovascular Diseases, Early Detection to Track Heart Conditions to Propel Global Market
Ambulatory cardiac monitoring devices help monitor the heart continuously, which leads to the detection of chronic heart conditions such as stroke and heart failure. By focusing on functional and structural abnormalities of the arteries and heart, it should, therefore be possible to identify and track the progression of disease.
Prominent Regions
In terms of region, the global ambulatory cardiac monitoring devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America dominated the global ambulatory cardiac monitoring devices market in 2020, followed by Europe and Asia Pacific. North America is projected to be a highly attractive market from 2021 to 2031. Significant revenue from the region can be attributed to increase in government and private funding and large volume of tests performed for cardiac diseases. Moreover, high prevalence of heart failure due to aging population and changes in dietary habits are anticipated to drive the global ambulatory cardiac monitoring devices market in North America.
The ambulatory cardiac monitoring devices market in Asia Pacific is expected to be driven by high adoption of ambulatory cardiac monitoring devices. According to a study published in the Radcliffe Cardiology journal, heart failure is a major health problem in Asia Pacific and its prevalence seems to be higher than countries in the West. Rise in awareness about heart failure and risk of sudden cardiac arrest associated with this condition propels the market in the region.
Key Players
Market Segmentation
By Type
By Region
In this study, the years considered to estimate the market size are as follows:
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Ambulatory Cardiac Monitoring Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Prevalence of Heart Failure
5.2. Brand Analysis
5.3. Patient Pathway for Ambulatory Cardiac Monitoring
5.4. Value Chain Analysis
5.5. Pricing Analysis
5.6. Reimbursement Scenario
5.7. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. ECG Devices
6.3.1.1. Resting ECG Devices
6.3.1.2. Stress ECG Devices
6.3.2. Holter Monitors
6.3.3. Event Monitors
6.3.4. Implantable Loop Recorders
6.3.5. Mobile Cardiac Telemetry
6.4. Market Attractiveness Analysis, by Type
7. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Country/Region
8. North America Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Type, 2017–2031
8.2.1. ECG Devices
8.2.1.1. Resting ECG Devices
8.2.1.2. Stress ECG Devices
8.2.2. Holter Monitors
8.2.3. Event Monitors
8.2.4. Implantable Loop Recorders
8.2.5. Mobile Cardiac Telemetry
8.3. Market Value Forecast, by Country, 2017–2031
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Type
8.4.2. By Country
9. Europe Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Type, 2017–2031
9.2.1. ECG Devices
9.2.1.1. Resting ECG Devices
9.2.1.2. Stress ECG Devices
9.2.2. Holter Monitors
9.2.3. Event Monitors
9.2.4. Implantable Loop Recorders
9.2.5. Mobile Cardiac Telemetry
9.3. Market Value Forecast, by Country/Sub-region, 2017–2031
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Type
9.4.2. By Country/Sub-region
10. Asia Pacific Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2031
10.2.1. ECG Devices
10.2.1.1. Resting ECG Devices
10.2.1.2. Stress ECG Devices
10.2.2. Holter Monitors
10.2.3. Event Monitors
10.2.4. Implantable Loop Recorders
10.2.5. Mobile Cardiac Telemetry
10.3. Market Value Forecast, by Country/Sub-region, 2017–2031
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Type
10.4.2. By Country/Sub-region
11. Latin America Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. ECG Devices
11.2.1.1. Resting ECG Devices
11.2.1.2. Stress ECG Devices
11.2.2. Holter Monitors
11.2.3. Event Monitors
11.2.4. Implantable Loop Recorders
11.2.5. Mobile Cardiac Telemetry
11.3. Market Value Forecast, by Country/Sub-region, 2017–2031
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Type
11.4.2. By Country/Sub-region
12. Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. ECG Devices
12.2.1.1. Resting ECG Devices
12.2.1.2. Stress ECG Devices
12.2.2. Holter Monitors
12.2.3. Event Monitors
12.2.4. Implantable Loop Recorders
12.2.5. Mobile Cardiac Telemetry
12.3. Market Value Forecast, by Country/Sub-region, 2017–2031
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Type
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Share Analysis, by Company, 2020
13.2. Company Profiles
13.2.1. Abbott
13.2.1.1. Company Overview
13.2.1.2. Company Financials
13.2.1.3. Growth Strategies
13.2.1.4. SWOT Analysis
13.2.2. Boston Scientific Corporation
13.2.2.1. Company Overview
13.2.2.2. Company Financials
13.2.2.3. Growth Strategies
13.2.2.4. SWOT Analysis
13.2.3. GE Healthcare
13.2.3.1. Company Overview
13.2.3.2. Company Financials
13.2.3.3. Growth Strategies
13.2.3.4. SWOT Analysis
13.2.4. Hill-Rom Holdings
13.2.4.1. Company Overview
13.2.4.2. Company Financials
13.2.4.3. Growth Strategies
13.2.4.4. SWOT Analysis
13.2.5. Koninklijke Philips N.V.
13.2.5.1. Company Overview
13.2.5.2. Company Financials
13.2.5.3. Growth Strategies
13.2.5.4. SWOT Analysis
13.2.6. Medtronic
13.2.6.1. Company Overview
13.2.6.2. Company Financials
13.2.6.3. Growth Strategies
13.2.6.4. SWOT Analysis
13.2.7. Nihon Kohden Corporation
13.2.7.1. Company Overview
13.2.7.2. Company Financials
13.2.7.3. Growth Strategies
13.2.7.4. SWOT Analysis
13.2.8. Asahi Kasei Medical Co., Ltd.
13.2.8.1. Company Overview
13.2.8.2. Company Financials
13.2.8.3. Growth Strategies
13.2.8.4. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers